• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (26)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Psychiatry  • Depression  • Psychopharmacology  • Cardiovascular System  • Drug Therapy  • Adverse Effects  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Christopher M. O’Connor, MD; Wei Jiang, MD; Maragatha Kuchibhatla, PhD; Rajendra H. Mehta, MD, MS; Greg L. Clary, MD; Michael S. Cuffe, MD; Eric J. Christopher, MD; Jude D. Alexander, MD; Robert M. Califf, MD; Ranga R. Krishnan, MD

Arch Intern Med. 2008;168(20):2232-2237.

Background  Recent studies suggest that the use of antidepressants may be associated with increased mortality in patients with cardiac disease. Because depression has also been shown to be associated with increased mortality in these patients, it remains unclear if this association is attributable to the use of antidepressants or to depression.

Methods  To evaluate the association of long-term mortality with antidepressant use and depression, we studied 1006 patients aged 18 years or older with clinical heart failure and an ejection fraction of 35% or less (62% with ischemic disease) between March 1997 and June 2003. The patients were followed up for vital status annually thereafter. Depression status, which was assessed by the Beck Depression Inventory (BDI) scale and use of antidepressants, was prospectively collected. The main outcome of interest was long-term mortality.

Results  Of the study patients, 30.0% were depressed (defined by a BDI score 10) and 24.2% were taking antidepressants (79.6% of these patients were taking selective serotonin reuptake inhibitors [SSRIs] only). The vital status was obtained from all participants at an average follow-up of 972 (731) (mean [SD]) days. During this period, 42.7% of the participants died. Overall, the use of antidepressants (unadjusted hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.03-1.69) or SSRIs only (unadjusted HR, 1.32; 95% CI, 0.99-1.74) was associated with increased mortality. However, the association between antidepressant use (HR, 1.24; 95% CI, 0.94-1.64) and increased mortality no longer existed after depression and other confounders were controlled for. Nonetheless, depression remained associated with increased mortality (HR, 1.33; 95% CI, 1.07-1.66). Similarly, depression (HR, 1.34; 95% CI, 1.08-1.68) rather than SSRI use (HR, 1.10; 95% CI, 0.81-1.50) was independently associated with increased mortality after adjustment.

Conclusion  Our findings suggest that depression (defined by a BDI score 10), but not antidepressant use, is associated with increased mortality in patients with heart failure.

Author Affiliations: Departments of Medicine (Drs O’Connor, Jiang, Mehta, Clary, Cuffe, Christopher, and Califf) and Psychiatry and Behavioral Sciences (Drs Jiang, Clary, Christopher, and Krishnan), and Aging Center (Dr Kuchibhatla), Duke University Medical Center, Durham, North Carolina; and Medicine/Psychiatry Services, Shady Grove Adventist Hospital, Rockville, Maryland (Dr Alexander).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(20):2182.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey
Hamer et al.
Eur Heart J 2011;32:437-442.
ABSTRACT | FULL TEXT  

Worsening Depressive Symptoms Are Associated With Adverse Clinical Outcomes in Patients With Heart Failure
Sherwood et al.
J Am Coll Cardiol 2011;57:418-423.
ABSTRACT | FULL TEXT  

Assessment of Depression in Heart Failure Patients: What Is the Role for Cardiology?
Connerney and Shapiro
J Am Coll Cardiol 2011;57:424-426.
FULL TEXT  

Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) Trial
O'Connor et al.
J Am Coll Cardiol 2010;56:692-699.
ABSTRACT | FULL TEXT  

Antidepressant Medication Use for Primary Care Patients with and without Medical Comorbidities: A National Electronic Health Record (EHR) Network Study
Gill et al.
J Am Board Fam Med 2010;23:499-508.
ABSTRACT | FULL TEXT  

Antidepressant Use, Depression, and Poor Cardiovascular Outcomes: The Chicken or the Egg?: Comment on "Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study"
O'Connor and Fiuzat
Arch Intern Med 2009;169:2140-2141.
FULL TEXT  

Depression After Coronary Artery Disease Is Associated With Heart Failure
May et al.
J Am Coll Cardiol 2009;53:1440-1447.
ABSTRACT | FULL TEXT  

Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk
Denollet and Pedersen
J Am Coll Cardiol 2009;53:947-949.
FULL TEXT  

Do Depression or Antidepressants Increase Cardiovascular Mortality?: The Absence of Proof Might Be More Important Than the Proof of Absence
Narayan and Stein
J Am Coll Cardiol 2009;53:959-961.
FULL TEXT  

CHAPTER 23 Heart Failure
McMurray et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT